Clinical Trials Logo

Stomach Diseases clinical trials

View clinical trials related to Stomach Diseases.

Filter by:

NCT ID: NCT06273319 Not yet recruiting - Gastric Disease Clinical Trials

The Effect of Oxygen Application With Double Nasal Cannula on Respiratory Complications

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

To compare desaturation and respiratory complications by applying oxygen therapy with double nasal cannula to patients who are planned to undergo gastrointestinal endoscopy.

NCT ID: NCT06213948 Recruiting - Healthy Clinical Trials

Elucidating Mechanisms That Underlie the Symptomatology of Functional Dyspepsia Using Novel Techniques and Its Therapeutic Validation Using Neuromodulators

Start date: August 1, 2021
Phase: Phase 1
Study type: Interventional

The goal of this study is to investigate the mechanisms of impaired gastric accommodation and emptying, dysfunctional duodenum, and micro-inflammation using novel imaging techniques of SPECT/CT, gastric emptying scintigraphy, MRI, high-resolution manometry, and inflammatory biomarkers, as well as to validate these mechanisms using a therapeutic trial of neuromodulator (mirtazapine) in functional dyspepsia (FD) and health. The main objective[s] it aims to answer are: - to investigate impaired gastric accommodation through SPECT/CT imaging and high-resolution manometry findings of the stomach fundus. - to investigate impaired gastric emptying through gastric emptying scintigraphy - to investigate for a dysfunctional duodenum through MRI imaging of the duodenum. - to investigate micro-inflammation through SPECT/CT standard uptake value (SUV), inflammatory biomarkers (eosinophils, mast cells, IL-6, IL-10) and mucosal barrier marker (E-cadherin). - to investigate if a therapeutic trial of a neuromodulator agent, mirtazapine, ameliorates symptoms of FD through improvement in impaired gastric accommodation. For objectives 1-4, FD patients and healthy volunteers will be consecutively recruited, and all will undergo SPECT/CT, MRI, high-resolution manometry and biomarkers, and data acquired from these tests will be analyzed. For objective 5, the enrolled participants who did all baseline tests/markers are given mirtazapine for four weeks, and all tests/markers, except biomarkers and MRI, are repeated at the end of the trial

NCT ID: NCT06212206 Not yet recruiting - Gastric Disease Clinical Trials

PillBotâ„¢ - Remotely Controlled Capsule Endoscopy

Start date: May 2024
Phase: N/A
Study type: Interventional

The PillBot System is an endoscopic capsule imaging system intended for visualization of the stomach. In contrast to currently used passive capsule endoscopy systems, and FDA cleared active magnetic system, the PillBot System uses active, motorized propulsion technology to facilitate the navigation and positioning of the capsule within the stomach anatomy for imaging of the gastric mucosa by an operator

NCT ID: NCT06027060 Not yet recruiting - Clinical trials for NSAID-Associated Gastropathy

Observational Study on Monitoring NSAID-Induced Gastropathy in Patients Using Magnetically-Controlled Capsule Gastroscopy

Start date: September 1, 2023
Phase:
Study type: Observational

The objective of this study is to observe gastric mucosal injuries in NSAID and non-NSAID users with magnetically-controlled capsule gastroscopy, and explore the effects of NSAIDs on gastric mucosal damage.

NCT ID: NCT05801055 Not yet recruiting - Gastric Disease Clinical Trials

A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and Simethicone

Start date: April 1, 2023
Phase: Phase 3
Study type: Interventional

Endoscopy is the diagnostic modality for most gastroduodenal diseases. During endoscopy mucus and foam may actually interfere with the visibility of the stomach mucosa. So the mixture of mucolytic ( N-acetyl cysteine) and anti-foaming agents ( simethicone) agents may disperse the bubbles and mucus in the stomach and enhance gastric visibility. This unique combination drink given 20-30 minutes prior to endoscopy is absolutely safe. There are previous studies from India, which was retrospective study. So, we have planned to conduct this randomized controlled trial on this issue. Adult patients undergoing diagnostic endoscopy will be randomized and one group (100 patients) will be given the combination drink whereas another group 9100 patients) will undergo an endoscopy after overnight fasting only, as a placebo drink may actually hamper the endoscopic visibility. Our primary outcome, gastric visibility will be assessed using a standard visibility scoring system.

NCT ID: NCT05676164 Completed - Clinical trials for Unspecified Disorder of Stomach and Duodenum

A Study to Evaluate the Safety and Efficacy of Oral Contrast Agent for Sonography

Start date: March 31, 2021
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to verify the safety and efficacy of Oral Contrast Agent for Sonography produced by Shandong Baiduo Medical Instruments Co., LTD.

NCT ID: NCT05602935 Active, not recruiting - Neoplasms Clinical Trials

Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study

Start date: September 16, 2020
Phase: Phase 2
Study type: Interventional

This is a single-arm, phase II study of camrelizumab combined with SOX regimen in subjects with resectable locally advanced gastric cancer. The patients will receive camrelizumab ,S-1 and oxaliplatin given every 3 weeks for 3 cycles as neoadjuvant therapy. After the surgery, adjuvant therapy which includes camrelizumab and SOX regimen will begin.

NCT ID: NCT05392452 Completed - Clinical trials for Diabetes Mellitus, Type 2

Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)

CLAB
Start date: August 9, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the efficacy, safety and usability of perioperative fully-automated closed-loop insulin delivery versus standard insulin therapy in patients with diabetes other than type 1 diabetes undergoing elective major abdominal surgery.

NCT ID: NCT05249933 Recruiting - Capsule Endoscopy Clinical Trials

Pronase Granules in Gastric Cleaning

Start date: February 24, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Magnetically controlled capsule endoscopy (MCE) is now widely used all over the world. However, the standard gastric preparation method by dimethicone we used clinically still has mucus at the bottom of the stomach. In this study, we aimed to determine whether pronase granules is helpful to improve the cleanliness of gastric mucosa in MCE.

NCT ID: NCT05182983 Completed - Liver Diseases Clinical Trials

Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis

Start date: November 15, 2020
Phase:
Study type: Observational

The tongue images of patients with gastrointestinal diseases and healthy people will be collected and the tongue image database will be established. Through deep learning and artificial intelligence, early screening models of various gastrointestinal tumors based on tongue images were constructed.